Organigram Holdings | OGI - 净收入



金融业
股票价格
CAD
资产
CAD 521.31M
现金及等价物
CAD 4.29M
销售成本
CAD 43.39M
流动资产
CAD 250.09M
流动负债
CAD 88.75M
债务
CAD 8.2M
EBIT
CAD -9.79M
EBITDA
CAD -4.76M
员工
1.14K
EPS每股收益
CAD -0.01
股本和储备
CAD 371.81M
销售毛利
CAD 16.41M
债务利息支出
CAD 179K
贷款资金
CAD 60.76M
市值
CAD 138.87M
净收入
CAD -921K
营业费用
CAD 69.59M
营业利润
CAD -9.79M
普通股股本
CAD 136.47M
PE价格收益
12.01
税前利润
CAD -921K
销售收入
CAD 59.79M
销售和管理费用
CAD 22.01M
股票
CAD 135.16M
贸易债权人
CAD 73.14M
应收帐款人
CAD 53.39M


净收入 更改 日
Acasti Pharma USD -938K 2.42M 2025-09
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.01M 153K 2026-03
Aurora Cannabis CAD -71.1M 72.92M 2026-03
Avita Medical AUD -11.62M 1.7M 2025-12
Canopy Growth CAD -157.11M 94.49M 2026-03
Cronos Group USD 13.75M 15.57M 2026-03
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
IQVIA Holdings USD 274M 240M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Moderna USD -1.34B 517M 2026-03
Organigram Holdings CAD -921K 20.89M 2026-03
Organon & Co USD 146M 351M 2026-03
Revvity USD 40.72M 57.65M 2026-03
Tectonic Therapeutic USD -25.24M 6.02M 2026-03
Tilray USD -44.93M 44.61M 2025-09
Viatris USD 176.4M 516.5M 2026-03
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03